{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T09:59:29Z","timestamp":1787047169672,"version":"build-2736575974"},"reference-count":117,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>As a set of inflammatory disorders, spondyloarthritis (SpA) exhibits distinct pathophysiological, clinical, radiological, and genetic characteristics. Due to the extra-articular features of this disorder, early recognition is crucial to limiting disability and improving outcomes. Gut dysbiosis has been linked to SpA development as evidence grows. A pathogenic SpA process is likely to occur when a mucosal immune system interacts with abnormal local microbiota, with subsequent joint involvement. It is largely unknown, however, how microbiota alterations predate the onset of SpA within the \u201cgut-joint axis\u201d. New microbiome therapies, such as probiotics, are used as an adjuvant therapy in the treatment of SpA, suggesting that the modulation of intestinal microbiota and\/or intestinal barrier function may contribute to the prevention of SpA. In this review, we highlight the mechanisms of SpA by which the gut microbiota impacts gut inflammation and triggers the activation of immune responses. Additionally, we analyze the regulatory role of therapeutic SpA medication in the gut microbiota and the potential application of probiotics as adjunctive therapy for SpA.<\/jats:p>","DOI":"10.3389\/fcimb.2022.973563","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T06:21:50Z","timestamp":1661149310000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Emerging story of gut dysbiosis in spondyloarthropathy: From gastrointestinal inflammation to spondyloarthritis"],"prefix":"10.3389","volume":"12","author":[{"given":"Xing","family":"Lyu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingjie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/nu12082189","article-title":"Postbiotics-a step beyond pre- and probiotics","volume":"12","author":"\u017b\u00f3\u0142kiewicz","year":"2020","journal-title":"Nutrients"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1186\/s13099-019-0341-6","article-title":"Microbial imbalance in inflammatory bowel disease patients at different taxonomic levels","volume":"12","author":"Alam","year":"2020","journal-title":"Gut Pathog."},{"key":"B3","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.jaci.2014.11.001","article-title":"The 3 major types of innate and adaptive cell-mediated effector immunity","volume":"135","author":"Annunziato","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/art.41622","article-title":"The pretreatment gut microbiome is associated with lack of response to methotrexate in new-onset rheumatoid arthritis","volume":"73","author":"Artacho","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1080\/10408398.2011.619671","article-title":"Immune system stimulation by probiotic microorganisms","volume":"54","author":"Ashraf","year":"2014","journal-title":"Crit. Rev. Food. Sci. Nutr."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1002\/art.40917","article-title":"HLA alleles associated with risk of ankylosing spondylitis and rheumatoid arthritis influence the gut microbiome","volume":"71","author":"Asquith","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-23571-4","article-title":"Microbiota composition may predict anti-tnf alpha response in spondyloarthritis patients: an exploratory study","volume":"8","author":"Bazin","year":"2018","journal-title":"Sci. Rep."},{"key":"B8","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1159\/000342079","article-title":"Probiotic mechanisms of action","volume":"61","author":"Bermudez-Brito","year":"2012","journal-title":"Ann. Nutr. Metab."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1111\/j.1572-0241.2005.41794.x","article-title":"VSL3 probiotic-mixture induces remission in patients with active ulcerative colitis","volume":"100","author":"Bibiloni","year":"2005","journal-title":"Am. J. Gastroenterol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/nrrheum.2017.92","article-title":"Pain in ankylosing spondylitis: a neuro-immune collaboration","volume":"13","author":"Bidad","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10787-019-00595-4","article-title":"A randomised, double-blind, placebo-controlled trial of a multi-strain probiotic in patients with asymptomatic ulcerative colitis and crohn\u2019s disease","volume":"27","author":"Bjarnason","year":"2019","journal-title":"Inflammopharmacology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s00535-008-2296-0","article-title":"Probiotics and immunity","volume":"44","author":"Borchers","year":"2009","journal-title":"J. Gastroenterol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1097\/01.mib.0000175905.00212.2c","article-title":"A randomized, double-blind trial of lactobacillus GG versus placebo in addition to standard maintenance therapy for children with crohn\u2019s disease","volume":"11","author":"Bousvaros","year":"2005","journal-title":"Inflamm. Bowel. Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1586\/17474124.2015.1057122","article-title":"Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease","volume":"9","author":"Brandl","year":"2015","journal-title":"Expert. Rev. Gastroenterol. Hepatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1136\/annrheumdis-2016-211064","article-title":"Faecal microbiota study reveals specific dysbiosis in spondyloarthritis","volume":"76","author":"Breban","year":"2017","journal-title":"Ann. Rheumatol. Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10787-015-0232-5","article-title":"A history of the term \u201cDMARD\u201d","volume":"23","author":"Buer","year":"2015","journal-title":"Inflammopharmacology"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.700570","article-title":"Adalimumab therapy restores the gut microbiota in patients with ankylosing spondylitis","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Immunol."},{"key":"B18","first-page":"723","article-title":"Use of synthetic and biological DMARDs in patients with enteropathic spondyloarthritis: a combined gastro-rheumatological approach","volume":"37","author":"Chimenti","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1136\/annrheumdis-2016-210000","article-title":"Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis","volume":"76","author":"Ciccia","year":"2017","journal-title":"Ann. Rheumatol. Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1038\/s41598-018-22125-y","article-title":"Gut microbial composition in patients with psoriasis","volume":"8","author":"Codoner","year":"2018","journal-title":"Sci. Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/art.38967","article-title":"Brief report: Intestinal dysbiosis in ankylosing spondylitis","volume":"67","author":"Costello","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.578386","article-title":"Anti-inflammatory and immunomodulatory effects of probiotics in gut inflammation: A door to the body","volume":"12","author":"Cristofori","year":"2021","journal-title":"Front. Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.tim.2021.01.003","article-title":"Shaping the future of probiotics and prebiotics","volume":"29","author":"Cunningham","year":"2021","journal-title":"Trends Microbiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41584-022-00761-z","article-title":"Treatment of axial spondyloarthritis: an update","volume":"18","author":"Danve","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2021-001755","article-title":"Intestinal microbiota changes induced by TNF-inhibitors in IBD-related spondyloarthritis","volume":"7","author":"Ditto","year":"2021","journal-title":"RMD Open"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/S0140-6736(11)60071-8","article-title":"Spondyloarthritis","volume":"377","author":"Dougados","year":"2011","journal-title":"Lancet"},{"key":"B27","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.pop.2018.02.005","article-title":"The seronegative spondyloarthropathies","volume":"45","author":"Duba","year":"2018","journal-title":"Prim. Care"},{"key":"B28","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/BOR.0000000000000402","article-title":"Axial spondyloarthritis classification criteria: the debate continues","volume":"29","author":"Dubreuil","year":"2017","journal-title":"Curr. Opin. Rheumatol."},{"key":"B29","first-page":"178","article-title":"The intestinal microbiome in human health and disease","volume":"131","author":"Dupont","year":"2020","journal-title":"Trans. Am. Clin. Climatol. Assoc."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.3748\/wjg.v25.i18.2162","article-title":"Inflammatory bowel diseases and spondyloarthropathies: From pathogenesis to treatment","volume":"25","author":"Fragoulis","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1007\/s10067-020-05433-5","article-title":"Combination of methotrexate and sulfasalazine is an efficacious option for axial spondyloarthritis in a resource-limited, real-world clinical setting: a prospective cohort study","volume":"40","author":"Ganapati","year":"2021","journal-title":"Clin. Rheumatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/bor.0000000000000187","article-title":"The intestinal microbiome in spondyloarthritis","volume":"27","author":"Gill","year":"2015","journal-title":"Curr. Opin. Rheumatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1002\/art.41018","article-title":"Novel inter-omic analysis reveals relationships between diverse gut microbiota and host immune dysregulation in HLA-B27-Induced experimental spondyloarthritis","volume":"71","author":"Gill","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13075-019-1831-0","article-title":"Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritis","volume":"21","author":"Gladman","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1056\/NEJMoa1615977","article-title":"Tofacitinib for psoriatic arthritis in patients with an inadequate response to TNF inhibitors","volume":"377","author":"Gladman","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1136\/annrheumdis-2015-208902","article-title":"IL-7 primes IL-17 in mucosal-associated invariant T (MAIT) cells, which contribute to the Th17-axis in ankylosing spondylitis","volume":"75","author":"Gracey","year":"2016","journal-title":"Ann. Rheumatol. Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41584-020-0454-9","article-title":"Revisiting the gut-joint axis: links between gut inflammation and spondyloarthritis","volume":"16","author":"Gracey","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"325","DOI":"10.4161\/gmic.25487","article-title":"Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut","volume":"4","author":"Groeger","year":"2013","journal-title":"Gut Microbes"},{"key":"B39","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13073-017-0490-5","article-title":"A novel ruminococcus gnavus clade enriched in inflammatory bowel disease patients","volume":"9","author":"Hall","year":"2017","journal-title":"Genome Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.3748\/wjg.v16.i33.4145","article-title":"Effect of probiotics on pro-inflammatory cytokines and NF-kappaB activation in ulcerative colitis","volume":"16","author":"Hegazy","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","article-title":"The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic","volume":"11","author":"Hill","year":"2014","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-020711-074937","article-title":"The microbiome in infectious disease and inflammation","volume":"30","author":"Honda","year":"2012","journal-title":"Annu. Rev. Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1159\/000322977","article-title":"Beneficial effects of probiotic bifidobacterium and galacto-oligosaccharide in patients with ulcerative colitis: a randomized controlled study","volume":"84","author":"Ishikawa","year":"2011","journal-title":"Digestion"},{"key":"B44","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1093\/rheumatology\/keaa399","article-title":"First-line csDMARD monotherapy drug retention in psoriatic arthritis: methotrexate outperforms sulfasalazine","volume":"60","author":"Jacobs","year":"2021","journal-title":"Rheumatol. (Oxford)"},{"key":"B45","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/ecco-jcc\/jjw199","article-title":"The prevalence and incidence of axial and peripheral spondyloarthritis in inflammatory bowel disease: A systematic review and meta-analysis","volume":"11","author":"Karreman","year":"2017","journal-title":"J. Crohns Colitis"},{"key":"B46","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s13075-019-2018-4","article-title":"A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin","volume":"21","author":"Klingberg","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1136\/gut.2003.037747","article-title":"Maintaining remission of ulcerative colitis with the probiotic escherichia coli nissle 1917 is as effective as with standard mesalazine","volume":"53","author":"Kruis","year":"2004","journal-title":"Gut"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1128\/mSystems.00176-18","article-title":"Altered bacterial-fungal interkingdom networks in the guts of ankylosing spondylitis patients","volume":"4","author":"Li","year":"2019","journal-title":"mSystems"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.819992","article-title":"Emerging roles of mucosal-associated invariant T cells in rheumatology","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"S164","DOI":"10.1002\/jcph.1121","article-title":"Probiotics in disease prevention and treatment","volume":"58","author":"Liu","year":"2018","journal-title":"J. Clin. Pharmacol."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctcp.2020.101207","article-title":"A systematic review of the effects of probiotic administration in inflammatory arthritis","volume":"40","author":"Lowe","year":"2020","journal-title":"Complement. Ther. Clin. Pract."},{"key":"B52","doi-asserted-by":"publisher","first-page":"iv16","DOI":"10.1093\/rheumatology\/keab385","article-title":"Crossing the boundaries: IL-23 and its role in linking inflammation of the skin, gut and joints","volume":"60","author":"Lukasik","year":"2021","journal-title":"Rheumatol. (Oxford)"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1056\/NEJMra1600266","article-title":"The human intestinal microbiome in health and disease","volume":"375","author":"Lynch","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1016\/j.mayocp.2020.02.007","article-title":"Recognizing axial spondyloarthritis: A guide for primary care","volume":"95","author":"Magrey","year":"2020","journal-title":"Mayo Clin. Proc."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1007\/s10620-018-4946-2","article-title":"Efficacy of bifidobacterium breve fermented milk in maintaining remission of ulcerative colitis","volume":"63","author":"Matsuoka","year":"2018","journal-title":"Dig. Dis. Sci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11926-019-0834-9","article-title":"ILC3 in axial spondyloarthritis: the gut angle","volume":"21","author":"Mauro","year":"2019","journal-title":"Curr. Rheumatol. Rep."},{"key":"B57","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrrheum.2012.56","article-title":"Spondyloarthritis: Is methotrexate effective in psoriatic arthritis","volume":"8","author":"Mease","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.638867","article-title":"Microbiome or infections: Amyloid-containing biofilms as a trigger for complex human diseases","volume":"12","author":"Miller","year":"2021","journal-title":"Front. Immunol."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18040830","article-title":"Spondyloarthritis: Matrix metalloproteinasesas biomarkers of pathogenesis and response to tumor necrosis factor (TNF) inhibitors","volume":"18","author":"Moz","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1136\/annrheumdis-2021-221035","article-title":"Axial spondyloarthritis","volume":"80","author":"Navarro-Comp\u00e1n","year":"2021","journal-title":"Ann. Rheumatol. Dis."},{"key":"B61","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00535-017-1384-4","article-title":"Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease","volume":"53","author":"Nishino","year":"2018","journal-title":"J. Gastroenterol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrgastro.2017.88","article-title":"Gut microbiota and IBD: causation or correlation","volume":"14","author":"Ni","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1001\/jama.1966.03110200049016","article-title":"An \u201cexperimental\u201d epidemic of reiter\u2019s syndrome","volume":"198","author":"Noer","year":"1966","journal-title":"Jama"},{"key":"B64","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.autrev.2014.04.003","article-title":"Italian Expert panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease","volume":"13","author":"Olivieri","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2020.00157","article-title":"Benefits of probiotics in rheumatic diseases","volume":"7","author":"Oliviero","year":"2020","journal-title":"Front. Nutr."},{"key":"B66","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000452356","article-title":"Microbiota plays a key role in non-steroidal anti-inflammatory drug-induced small intestinal damage","volume":"95","author":"Otani","year":"2017","journal-title":"Digestion"},{"key":"B67","doi-asserted-by":"publisher","first-page":"372","DOI":"10.5507\/bp.2016.044","article-title":"The long-term effects of probiotics in the therapy of ulcerative colitis: A clinical study","volume":"160","author":"Palumbo","year":"2016","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky Olomouc. Czech. Repub."},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118450","article-title":"Short-term high-dose gavage of hydroxychloroquine changes gut microbiota but not the intestinal integrity and immunological responses in mice","volume":"264","author":"Pan","year":"2021","journal-title":"Life. Sci."},{"key":"B69","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1093\/advances\/nmy063","article-title":"Mechanisms of action of probiotics","volume":"10","author":"Plaza-Diaz","year":"2019","journal-title":"Adv. Nutr."},{"key":"B70","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1080\/1744666x.2018.1477591","article-title":"Radiographic progression in non-radiographic axial spondyloarthritis","volume":"14","author":"Protopopov","year":"2018","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1136\/annrheumdis-2019-215349","article-title":"Integrin and transcriptomic profiles identify a distinctive synovial CD8+T cell subpopulation in spondyloarthritis","volume":"78","author":"Qaiyum","year":"2019","journal-title":"Ann. Rheumatol. Dis."},{"key":"B72","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00281-021-00845-0","article-title":"The gut-joint axis in spondyloarthritis: immunological, microbial, and clinical insights","volume":"43","author":"Qaiyum","year":"2021","journal-title":"Semin. Immunopathol."},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.817884","article-title":"Do NSAIDs take us away from treatment goals in axial spondyloarthritis: A story about dysbiosis or just a matter of bias","volume":"8","author":"Queiro-Silva","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m4447","article-title":"Axial spondyloarthritis: new advances in diagnosis and management","volume":"372","author":"Ritchlin","year":"2021","journal-title":"BMJ"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00063","article-title":"Role of subclinical gut inflammation in the pathogenesis of spondyloarthritis","volume":"5","author":"Rizzo","year":"2018","journal-title":"Front. Med. (Lausanne)"},{"key":"B76","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41584-020-00552-4","article-title":"Axial spondyloarthritis: concept, construct, classification and implications for therapy","volume":"17","author":"Robinson","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1016\/j.cmi.2015.10.003","article-title":"The influence of non-steroidal anti-inflammatory drugs on the gut microbiome","volume":"22","author":"Rogers","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"B78","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nrrheum.2012.39","article-title":"Referral strategies for early diagnosis of axial spondyloarthritis","volume":"8","author":"Rudwaleit","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1136\/ard.2010.133645","article-title":"The assessment of SpondyloArthritis international society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general","volume":"70","author":"Rudwaleit","year":"2011","journal-title":"Ann. Rheumatol. Dis."},{"key":"B80","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3109\/00498254.2013.811314","article-title":"Bacterial beta-glucuronidase inhibition protects mice against enteropathy induced by indomethacin, ketoprofen or diclofenac: mode of action and pharmacokinetics","volume":"44","author":"Saitta","year":"2014","journal-title":"Xenobiotica"},{"key":"B81","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3390\/nu14020354","article-title":"Efficacy of probiotics in rheumatoid arthritis and spondyloarthritis: A systematic review and meta-analysis of randomized controlled trials","volume":"14","author":"Sanchez","year":"2022","journal-title":"Nutrients"},{"key":"B82","first-page":"233","article-title":"Probiotics in spondyloarthropathy associated with ulcerative colitis: a pilot study","volume":"13","author":"Sanges","year":"2009","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B83","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41584-020-0395-3","article-title":"Pharmacomicrobiomics in inflammatory arthritis: gut microbiome as modulator of therapeutic response","volume":"16","author":"Scher","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/art.38892","article-title":"Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease","volume":"67","author":"Scher","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.3899\/jrheum.201111","article-title":"Secukinumab efficacy on enthesitis in patients with ankylosing spondylitis: Pooled analysis of four pivotal phase III studies","volume":"48","author":"Schett","year":"2021","journal-title":"J. Rheumatol."},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.637829","article-title":"Role of the IL-23\/IL-17 pathway in rheumatic diseases: An overview","volume":"12","author":"Schinocca","year":"2021","journal-title":"Front. Immunol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1152\/physrev.00045.2009","article-title":"Gut microbiota in health and disease","volume":"90","author":"Sekirov","year":"2010","journal-title":"Physiol. Rev."},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104344","article-title":"Recent advances in gut microbiota mediated therapeutic targets in inflammatory bowel diseases: Emerging modalities for future pharmacological implications","volume":"148","author":"Shamoon","year":"2019","journal-title":"Pharmacol. Res."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nm.2817","article-title":"IL-23 induces spondyloarthropathy by acting on ROR-gammat+ CD3+CD4-CD8- entheseal resident T cells","volume":"18","author":"Sherlock","year":"2012","journal-title":"Nat. Med."},{"key":"B90","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0140-6736(16)31591-4","article-title":"Axial spondyloarthritis","volume":"390","author":"Sieper","year":"2017","journal-title":"Lancet"},{"key":"B91","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1136\/ard.2008.104018","article-title":"The assessment of SpondyloArthritis international society (ASAS) handbook: a guide to assess spondyloarthritis","author":"Sieper","year":"2009","journal-title":"Ann. Rheumatol. Dis."},{"key":"B92","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/art.38291","article-title":"Review: The interleukin-23\/interleukin-17 axis in spondyloarthritis pathogenesis: Th17 and beyond","volume":"66","author":"Smith","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1136\/annrheumdis-2019-216655","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update","volume":"79","author":"Smolen","year":"2020","journal-title":"Ann. Rheumatol. Dis."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1209.e1201","DOI":"10.1016\/j.cgh.2009.07.016","article-title":"The probiotic preparation, VSL3 induces remission in patients with mild-to-moderately active ulcerative colitis","volume":"7","author":"Sood","year":"2009","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.rdc.2012.09.003","article-title":"Epidemiology of spondyloarthritis","volume":"38","author":"Stolwijk","year":"2012","journal-title":"Rheumatol. Dis. Clin. North Am."},{"key":"B96","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41584-018-0044-2","article-title":"IL-17 in the immunopathogenesis of spondyloarthritis","volume":"14","author":"Taams","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/den.12553","article-title":"Efficacy of probiotic treatment with bifidobacterium longum 536 for induction of remission in active ulcerative colitis: A randomized, double-blinded, placebo-controlled multicenter trial","volume":"28","author":"Tamaki","year":"2016","journal-title":"Dig. Endosc."},{"key":"B98","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1084\/jem.180.6.2359","article-title":"The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats","volume":"180","author":"Taurog","year":"1994","journal-title":"J. Exp. Med."},{"key":"B99","first-page":"1","article-title":"One year in review 2017: spondyloarthritis","volume":"36","author":"Terenzi","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"G602","DOI":"10.1152\/ajpgi.00230.2019","article-title":"Dysbiosis: from fiction to function","volume":"317","author":"Tiffany","year":"2019","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/art.39802","article-title":"Dialister as a microbial marker of disease activity in spondyloarthritis","volume":"69","author":"Tito","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3390\/ph15030270","article-title":"The use of janus kinase inhibitors in axial spondyloarthritis: Current insights","volume":"15","author":"Toussirot","year":"2022","journal-title":"Pharm. (Basel)"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2018-000821","article-title":"MAIT cells: potent major cellular players in the IL-17 pathway of spondyloarthritis","volume":"4","author":"Toussirot","year":"2018","journal-title":"RMD Open"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176401","article-title":"The role of the IL-23\/IL-17 pathway in the pathogenesis of spondyloarthritis","volume":"21","author":"Tsukazaki","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B105","first-page":"128","article-title":"Bowel permeability and CD45RO expression on circulating CD20+ b cells in patients with ankylosing spondylitis and their relatives","volume":"26","author":"Vaile","year":"1999","journal-title":"J. Rheumatol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.afnr.2020.06.001","article-title":"Postbiotics and paraprobiotics: A review of current evidence and emerging trends","volume":"94","author":"Vallejo-Cordoba","year":"2020","journal-title":"Adv. Food. Nutr. Res."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1093\/rheumatology\/kez420","article-title":"Secukinumab provides sustained low rates of radiographic progression in psoriatic arthritis: 52-week results from a phase 3 study, FUTURE 5","volume":"59","author":"van der Heijde","year":"2020","journal-title":"Rheumatol. (Oxford)"},{"key":"B108","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","article-title":"2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis","volume":"76","author":"van der Heijde","year":"2017","journal-title":"Ann. Rheumatol. Dis."},{"key":"B109","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/rheumatology\/key070","article-title":"The rationale for janus kinase inhibitors for the treatment of spondyloarthritis","volume":"58","author":"Veale","year":"2019","journal-title":"Rheumatol. (Oxford)"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1002\/acr.24025","article-title":"2019 update of the American college of Rheumatology\/Spondylitis association of America\/Spondyloarthritis research and treatment network recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis","volume":"71","author":"Ward","year":"2019","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"B111","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13059-017-1271-6","article-title":"Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis","volume":"18","author":"Wen","year":"2017","journal-title":"Genome Biol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.crohns.2010.11.004","article-title":"A randomised double-blind placebo-controlled trial with lactobacillus acidophilus la-5 and bifidobacterium animalis subsp. lactis BB-12 for maintenance of remission in ulcerative colitis","volume":"5","author":"Wildt","year":"2011","journal-title":"J. Crohns Colitis"},{"key":"B113","first-page":"69","article-title":"Spondyloarthropathies: new directions in etiopathogenesis, diagnosis and treatment","volume":"109","author":"Wilson","year":"2012","journal-title":"Mo. Med."},{"key":"B114","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1136\/annrheumdis-2019-215763","article-title":"Shotgun metagenomics reveals an enrichment of potentially cross-reactive bacterial epitopes in ankylosing spondylitis patients, as well as the effects of TNFi therapy upon microbiome composition","volume":"79","author":"Yin","year":"2020","journal-title":"Ann. Rheumatol. Dis."},{"key":"B115","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41584-021-00585-3","article-title":"The gut-joint axis in rheumatoid arthritis","volume":"17","author":"Zaiss","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"key":"B116","first-page":"99","article-title":"Dynamic variations in gut microbiota in ankylosing spondylitis patients treated with anti-TNF-\u03b1 for six months","volume":"50","author":"Zhang","year":"2020","journal-title":"Ann. Clin. Lab. Sci."},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.01703","article-title":"Modulation of gut microbiome composition and function in experimental colitis treated with sulfasalazine","volume":"8","author":"Zheng","year":"2017","journal-title":"Front. Microbiol."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.973563\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T06:22:00Z","timestamp":1661149320000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.973563\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,22]]},"references-count":117,"alternative-id":["10.3389\/fcimb.2022.973563"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2022.973563","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,22]]},"article-number":"973563"}}